L V Prasad Eye Institute (LVPEI) in partnership with Dr May Griffith and her team of scientists from the Linkping University, Sweden, and with the financial backing of Tej Kohli and his Foundation today inaugurated Tej Kohli Cornea Institute at LVPEI here.
The Centre was inaugurated by Andhra Pradesh & Telangana Governor ESL Narasimhan and Telangana IT Minister K T Rama Rao.
In his welcome address , LVPEI Founder Chairman Dr Gullapalli N Rao said We are proud of our long standing history and global reputation in the area of ophthalmology. We have spent over 27 years working with leading specialists in their given field, to deliver the best possible outcomes for our patients. This is a vital opportunity to extend this work as new technologies can be implemented to help in reducing corneal blindness. L V Prasad Eye Institute has created history in the field of Corneal Transplantation by becoming the first single Institute ever in the world to achieve 20,000 corneal transplants across its network. Through the new Tej Kohli Cornea Institute, and with Dr May Griffith and her team, we are now able to go beyond this and explore the use of synthetic lenses. With this new Institute, we hope to enhance our activities significantly both directly and indirectly as well as developing a Global Resource Centre for corneal blindness. This means being able to increase the number of surgeries we can undertake and work towards our own goal of eliminating avoidable blindness. This philanthropic gesture of Mr Kohli opens up all these possibilities.
This is a seminal moment for myself and my team as we take the world of ophthalmology into the future. I have tirelessly sought to find new ways that will alleviate the simple forms of blindness, whilst looking at the wider possibilities. With the Tej Kohli Foundations long-term financial commitment, we are now in a position to strategically plan for the future, both in terms of the necessary time line research it takes and the evolution of new products and techniques, Dr May Griffith, Professor of Regenerative Medicine, Linkping University, Sweden said.MORE UNI VV RJ 2329
-- (UNI) -- C-1-1-DL0109-483297.Xml